Medication-Related Osteonecrosis of the Jaws: Bisphosphonates, Denosumab, and New Agents

Osteonecrosis of the jaws represents a significant concern for patients undergoing antiresorptive therapy, particularly those treated with bisphosphonates and denosumab. Sven Otto delves into the complexities of this condition, shedding light on its causes, symptoms, and the mechanisms that contribute to its emergence. The author masterfully navigates through the clinical implications faced by healthcare providers and patients alike, making this an essential read for those directly impacted by this serious complication.

The book provides a comprehensive overview of the evolving landscape of treatments designed to mitigate the risks associated with medication-related osteonecrosis. Otto discusses the latest agents currently under investigation, expanding the reader’s understanding of potential therapies and their efficacy. He emphasizes the importance of awareness among dental and medical professionals, as early detection and intervention can significantly alter outcomes for affected individuals.

With clear explanations and insightful analysis, this work serves as a critical resource for practitioners, researchers, and students eager to understand the intersection of pharmacology and dental health. It invites a deeper recognition of the challenges posed by these medications, underscoring the importance of informed patient management strategies in preserving jaw health.